Authors:
ROBAK T
GORATYBOR J
KRYKOWSKI E
WALEWSKI JA
BORAWSKA A
PLUZANSKA A
POTEMSKI P
HELLMANN A
ZAUCHA JM
KONOPKA L
CEGLAREK B
DURZYNSKI T
SIKORSKA A
MICHALAK K
URASINSKI J
OPALINSKA J
DMOSZYNSKA A
ADAMCZYKCIOCH MB
KURATOWSKA Z
DWILEWICZTROJACZEK J
BOGURADZKI P
DEREN M
MAJ S
GRIEB P
Citation: T. Robak et al., ACTIVITY OF 2-CHLORODEOXYADENOSINE (CLADRIBINE) IN 2-HOUR INTRAVENOUS-INFUSION IN 94 PREVIOUSLY TREATED PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 26(1-2), 1997, pp. 99-105
Authors:
ROBAK T
BLASINSKAMORAWIEC M
KRYKOWSKI E
HELLMANN A
LEWANDOWSKI K
DMOSZYNSKA A
ADAMCZYKCIOCH M
KAZIMIERCZAK M
TREPINSKA E
DWILEWICZTROJACZEK M
KURATOWSKA Z
SKOTNICKI AB
NOWAK WS
ZDZIARSKA B
URASINSKI I
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (CLADRIBINE)-RELATED EOSINOPHILIA IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES, European journal of haematology, 59(4), 1997, pp. 216-220
Authors:
ROBAK T
BLASINSKAMORAWIEC M
BLONSKI JZ
KRYKOWSKI E
DMOSZYNSKA A
SKOTNICKI AB
KONOPKA L
HELLMANN A
KURATOWSKA Z
URASINSKI I
KOTLAREKHAUS S
MAJ S
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (2-CDA) AND PREDNISONE(P) VERSUS CHLORAMBUCIL (CHL) AND PREDNISONE AS A FIRST LINE THERAPY IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 90(10), 1997, pp. 2361-2361
Authors:
ROBAK T
BLASINKAMORAWIEC M
KRYKOWSKI E
KASZNICKI M
PLUZANSKA A
POTEMSKI P
HELLMANN A
ZAUCHA JM
LEWANDOWSKI K
DMOSZYNSKA A
HANSZ J
KOMARNICKI M
KONOPKA I
DURZYNSKI T
CEGLAREK B
SIKORSKA A
KOTLAREKHAUS S
MAZUR G
URASINSKI I
ZDZIARSKA B
MAJ S
KOPEC I
SKOTNICKI AB
DWILEWICZTROJACZEK J
KURATOWSKA Z
GRIEB P
Citation: T. Robak et al., INTERMITTENT 2-HOUR INTRAVENOUS INFUSIONS OF 2-CHLORODEOXYADENOSINE IN THE TREATMENT OF 110 PATIENTS WITH REFRACTORY OR PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia & lymphoma, 22(5-6), 1996, pp. 509-514
Authors:
ROBAK T
BLASINSKAMORAWIEC M
KRYKOWSKI E
HANSZ J
KOMARNICKI M
KAZIMIERCZAK M
KONOPKA L
MAJ S
HELLMANN A
ZAUCHA JM
URASINSKI L
ZDZIARSKA B
KOTLAREKHAUS S
USNARSKAZUBKIEWICZ L
KURATOWSKA Z
DWILEWICZTROJACZEK J
HOLOWIECKI J
KRAWCZYKKULIS M
GRIEB P
Citation: T. Robak et al., 2-CHLORODEOXYADENOSINE (2-CDA) IN 2-HOUR VERSUS 24-HOUR INTRAVENOUS-INFUSION IN THE TREATMENT OF PATIENTS WITH HAIRY-CELL LEUKEMIA, Leukemia & lymphoma, 22(1-2), 1996, pp. 107-111